[Is transplantation an alternative to the transfusional impasse in sickle cell disease?]

Area of Science:

• Hematology
• Immunology
• Transplantation

Background:

• Sickle cell disease is the most common genetic disorder in France, affecting approximately 400 newborns annually.
• Afro-Caribbean patients with sickle cell disease often require transfusions from Caucasian donors, leading to significant challenges.
• Erythroid antigen disparities between Caucasian and African populations result in a high prevalence of allo-immunization, risking transfusion failure.

Purpose of the Study:

• To highlight the challenges in managing sickle cell disease patients requiring transfusions.
• To present allogeneic stem cell transplantation as the only curative option for sickle cell disease.
• To emphasize the necessity of collaboration between blood bank and transplantation teams for successful graft outcomes.

Main Methods:

• Review of current transfusion practices and challenges in sickle cell disease patients.
• Analysis of allo-immunization risks in Afro-Caribbean populations.
• Discussion of allogeneic stem cell transplantation as a curative approach, including graft management.

Main Results:

• Frequent transfusions in sickle cell disease patients, particularly those of Afro-Caribbean descent, lead to high rates of allo-immunization.
• Allogeneic stem cell transplantation is the sole curative treatment for sickle cell disease.
• Successful transplantation can resolve transfusion-related complications and achieve full donor chimerism.

Conclusions:

• Close collaboration between blood bank physicians and transplantation specialists is crucial for optimizing conditioning regimens and graft-versus-host disease prophylaxis.
• Careful management is required to ensure a successful transition from mixed to full donor chimerism for a curative graft.
• Allogeneic stem cell transplantation offers a definitive solution for sickle cell disease and associated transfusion complications.